University of Turku granted the Title of Docent to Kalle Rytkönen
Dr. Kalle Rytkönen was granted the title of Docent of Physiology and Functional Genomics by the Faculty of Medicine at the University of Turku.
His current research focuses on the gene regulation of the uterine endometrium and endometrium related disorders such as preeclampsia, endometriosis and heavy menstrual bleeding. To better understand the uterine biology and the roles of specific uterine cell types Dr. Rytkönen is utilizing transcriptomics and steroidomics in close collaboration with Matti Poutanen´s research group at the Institute of Biomedicine and Laura Elo´s research group at the Turku Bioscience Centre.
Recent Posts
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026
- BioCity Turku asks for proposals for Elias Tillandz publication prize winner during March 2026In the context of the 35th BioCity Symposium “Vision, Expanded” (27-28 August 2026) the twenty-second Read moreMarch 3, 2026